socalTECH

OCTOBER 14, 2013

San Diego-based Celladon , a clinical stage biopharmaceuticals firm which is developing enzymes to address calcium regulation, has filed for an IPO. Celladon is backed by Enterprise Partners, Pfizer, Lundbeckfond, Novartis Bioventures, J&J Development, GBS Bioventures, MPM Capital, Venrock, H&Q, as well as others.

Enterprise Partners 157

Enterprise Partners San Diego Acquisition Capital 157

socalTECH

AUGUST 23, 2013

San Diego-based XIFIN , which develops cloud-based financial software for the healthcare industry, has acquired Irvine-based PathCentral , a developer of software for the pathology community, the company announced Thursday afternoon. Financial details of the acquisition were not announced. READ MORE>>.

Windward 138

Windward Enterprise Partners San Diego Acquisition 138

socalTECH

JULY 30, 2014

San Diego-based XIFIN , a developer of cloud-based software for the healthcare diagnostics market, has been acquired by private equity investor GTCR. XIFIN''s backers include Boulder Ventures, Enterprise Partners, and Windward Ventures. Financial terms of the buy were not disclosed. GTCR said the investment came from its $3.85

Windward 138

Windward SaaS Enterprise Partners Equity 138

socalTECH

JUNE 30, 2010

San Diego-based TargeGen , a firm developing small molecule kinase inhibitors for the treatment of myelofibrosis (MF) and polycythemia vera (PV), has been acquired by Sanofi-aventis, in a deal worth as much as $560M, the firm said Wednesday. Tags: targegen sanofi aventis merger acquisition lifescience bioscience.

Enterprise Partners 140

Enterprise Partners San Diego Acquisition Pricing 140